首页 > 最新文献

中华预防医学杂志最新文献

英文 中文
[Expert recommendations on the development content and functional specifications for the public vaccination service platform]. 【关于公众预防接种服务平台开发内容和功能规范的专家建议】。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250609-00527
Q Zhu, Q L Ma, R L Xie, L J Liu, L Li, L Chen, Y Huang, R H Tan, X R Cai, J F He, W Z Yu

To satisfy the growing healthcare demands of the public, it is essential to develop a public service platform for vaccination. This initiative aligns with national policies, optimizes resource allocation, innovates service models, enhances service efficiency, and reduces service costs. Drawing on relevant national policies and regulatory requirements, as well as the notable achievements and practical experiences gained through the exploration and innovation of vaccination service models across various regions, this paper proposes expert recommendations. It defines the essential components and functional specifications for public service platforms, focusing on public needs such as electronic vaccination record management, appointment management, the promotion of electronic vaccination certificates, vaccination certificate verification for school enrollment, vaccination site navigation, and science communication and public engagement. The recommendations aim to serve as a reference for the development of vaccination public service platforms nationwide.

为满足公众日益增长的卫生保健需求,建立预防接种公共服务平台势在必行。“一带一路”倡议契合国家政策,优化资源配置,创新服务模式,提高服务效率,降低服务成本。结合国家相关政策和监管要求,结合各地探索创新疫苗接种服务模式取得的显著成果和实践经验,提出专家建议。明确了公共服务平台的基本组成部分和功能规范,重点围绕电子预防接种记录管理、预约管理、推广电子预防接种证书、学校入学预防接种证书核查、预防接种网站导航、科学传播和公众参与等公众需求。这些建议旨在为全国疫苗接种公共服务平台的发展提供参考。
{"title":"[Expert recommendations on the development content and functional specifications for the public vaccination service platform].","authors":"Q Zhu, Q L Ma, R L Xie, L J Liu, L Li, L Chen, Y Huang, R H Tan, X R Cai, J F He, W Z Yu","doi":"10.3760/cma.j.cn112150-20250609-00527","DOIUrl":"10.3760/cma.j.cn112150-20250609-00527","url":null,"abstract":"<p><p>To satisfy the growing healthcare demands of the public, it is essential to develop a public service platform for vaccination. This initiative aligns with national policies, optimizes resource allocation, innovates service models, enhances service efficiency, and reduces service costs. Drawing on relevant national policies and regulatory requirements, as well as the notable achievements and practical experiences gained through the exploration and innovation of vaccination service models across various regions, this paper proposes expert recommendations. It defines the essential components and functional specifications for public service platforms, focusing on public needs such as electronic vaccination record management, appointment management, the promotion of electronic vaccination certificates, vaccination certificate verification for school enrollment, vaccination site navigation, and science communication and public engagement. The recommendations aim to serve as a reference for the development of vaccination public service platforms nationwide.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1448-1453"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interpretation of the Chinese expert consensus on allergen component resolved diagnosis]. 【过敏原成分解析诊断中国专家共识解读】。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20241216-01043
J Y Wang, W T Luo, B Q Sun, G P Li

In recent years, the continuous rise in the prevalence of allergic diseases has posed a significant threat to public health in China. With advancements in molecular biology technologies, allergen component resolved diagnosis (CRD) has gradually become an essential tool for precise diagnosis and personalized treatment. The Allergy Prevention and Control Specialty Committee of the Chinese Preventive Medicine Association, in collaboration with multidisciplinary experts, has developed the Expert Consensus on Allergen Component Resolved Diagnosis in China. This article provides an in-depth interpretation of the expert consensus, aiming to assist clinicians and researchers in better understanding and utilizing CRD in the diagnosis and management of allergic diseases. It seeks to promote the standardized application and technological advancement of CRD in China, thereby enhancing the diagnosis and treatment of allergic diseases.

近年来,中国变态反应性疾病的患病率持续上升,对公共卫生构成了重大威胁。随着分子生物学技术的进步,过敏原成分分解诊断(CRD)逐渐成为精确诊断和个性化治疗的重要工具。中华预防医学会变态反应预防与控制专业委员会与多学科专家合作,制定了《中国变态反应原成分分解诊断专家共识》。本文对专家共识进行了深入解读,旨在帮助临床医生和研究人员更好地理解和利用CRD在变应性疾病的诊断和管理中。旨在促进CRD在中国的规范应用和技术进步,从而提高对变态反应性疾病的诊断和治疗。
{"title":"[Interpretation of the Chinese expert consensus on allergen component resolved diagnosis].","authors":"J Y Wang, W T Luo, B Q Sun, G P Li","doi":"10.3760/cma.j.cn112150-20241216-01043","DOIUrl":"10.3760/cma.j.cn112150-20241216-01043","url":null,"abstract":"<p><p>In recent years, the continuous rise in the prevalence of allergic diseases has posed a significant threat to public health in China. With advancements in molecular biology technologies, allergen component resolved diagnosis (CRD) has gradually become an essential tool for precise diagnosis and personalized treatment. The Allergy Prevention and Control Specialty Committee of the Chinese Preventive Medicine Association, in collaboration with multidisciplinary experts, has developed the <i>Expert Consensus on Allergen Component Resolved Diagnosis in China</i>. This article provides an in-depth interpretation of the expert consensus, aiming to assist clinicians and researchers in better understanding and utilizing CRD in the diagnosis and management of allergic diseases. It seeks to promote the standardized application and technological advancement of CRD in China, thereby enhancing the diagnosis and treatment of allergic diseases.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1390-1406"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advances in the mechanism and research of epithelial-derived alarmins in driving allergic diseases]. [上皮源性警报器驱动过敏性疾病的机制与研究进展]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20241128-00955
G G Huang, H Gan, Z Zhu

Allergen-associated proteases, pollutants, viral and fungal pathogens disrupted epithelial barrier integrity and promoted airway epithelial release of alarmins.Epithelial-derived Alarmins include thymic stromal lymphopoietin (TSLP), interleukin 33 (IL-33), and interleukin 25 (IL-25), which acted on a variety of effector cells such as dendritic cells (DCs), T-lymphocytes, innate lymphocyte cells (ILC2), B-lymphocytes, eosinophils, mast cells, basophils, and macrophages. T-lymphocytes, innate lymphocyte cell type 2 (ILC2), B-lymphocytes, eosinophils, mast cells, basophils and macrophages are the effector cells. By affecting the physiological and biochemical functions of target cells, such as proliferation and differentiation, survival and recruitment, and material metabolism, the alarmins had activated the intrinsic and adaptive immunity, and played a key role in allergic diseases such as bronchial asthma, atopic dermatitis, allergic rhinitis, and urticaria. A variety of monoclonal antibodies targeting epithelial-derived alarm factors have been developed for the above allergic diseases, and some of these products are already put into clinical use. As epidemiological studies showed that skin allergy closely related to airway allergy, allergic co-morbidities has imposed a heavy economic and psychological burden to patients. In-depth understanding the mechanism of alarmins will help to understand the developing and progression of allergic diseases, and develop more effective diagnostic and therapeutic strategies for allergic co-morbidities. This article reviews the mechanism and recent research advances of epithelial-derived alarmins in a variety of allergic diseases.

过敏原相关蛋白酶、污染物、病毒和真菌病原体破坏上皮屏障的完整性,促进气道上皮释放警报器。上皮来源的警报器包括胸腺基质淋巴生成素(TSLP)、白细胞介素33 (IL-33)和白细胞介素25 (IL-25),它们作用于多种效应细胞,如树突状细胞(dc)、t淋巴细胞、先天淋巴细胞(ILC2)、b淋巴细胞、嗜酸性细胞、肥大细胞、嗜碱性细胞和巨噬细胞。t淋巴细胞、先天淋巴细胞2型(ILC2)、b淋巴细胞、嗜酸性细胞、肥大细胞、嗜碱性细胞和巨噬细胞是效应细胞。通过影响靶细胞的增殖与分化、生存与募集、物质代谢等生理生化功能,激活固有免疫和适应性免疫,在支气管哮喘、特应性皮炎、变应性鼻炎、荨麻疹等变应性疾病中发挥关键作用。针对上述过敏性疾病已开发出多种靶向上皮源性报警因子的单克隆抗体,部分产品已投入临床使用。流行病学研究表明,皮肤过敏与气道过敏密切相关,过敏合并症给患者带来了沉重的经济和心理负担。深入了解警报器的作用机制,有助于了解变态反应性疾病的发生和发展,为变态反应性合并症制定更有效的诊断和治疗策略。本文就上皮源性警报器在各种变应性疾病中的作用机制及最新研究进展作一综述。
{"title":"[Advances in the mechanism and research of epithelial-derived alarmins in driving allergic diseases].","authors":"G G Huang, H Gan, Z Zhu","doi":"10.3760/cma.j.cn112150-20241128-00955","DOIUrl":"10.3760/cma.j.cn112150-20241128-00955","url":null,"abstract":"<p><p>Allergen-associated proteases, pollutants, viral and fungal pathogens disrupted epithelial barrier integrity and promoted airway epithelial release of alarmins.Epithelial-derived Alarmins include thymic stromal lymphopoietin (TSLP), interleukin 33 (IL-33), and interleukin 25 (IL-25), which acted on a variety of effector cells such as dendritic cells (DCs), T-lymphocytes, innate lymphocyte cells (ILC2), B-lymphocytes, eosinophils, mast cells, basophils, and macrophages. T-lymphocytes, innate lymphocyte cell type 2 (ILC2), B-lymphocytes, eosinophils, mast cells, basophils and macrophages are the effector cells. By affecting the physiological and biochemical functions of target cells, such as proliferation and differentiation, survival and recruitment, and material metabolism, the alarmins had activated the intrinsic and adaptive immunity, and played a key role in allergic diseases such as bronchial asthma, atopic dermatitis, allergic rhinitis, and urticaria. A variety of monoclonal antibodies targeting epithelial-derived alarm factors have been developed for the above allergic diseases, and some of these products are already put into clinical use. As epidemiological studies showed that skin allergy closely related to airway allergy, allergic co-morbidities has imposed a heavy economic and psychological burden to patients. In-depth understanding the mechanism of alarmins will help to understand the developing and progression of allergic diseases, and develop more effective diagnostic and therapeutic strategies for allergic co-morbidities. This article reviews the mechanism and recent research advances of epithelial-derived alarmins in a variety of allergic diseases.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1381-1389"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Reflections on the standardized management of vaccination units in the new era of high-quality development of China's immunization program]. [中国免疫规划高质量发展新时期预防接种单位规范管理的思考]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250115-00040
B B Wang, J H Tang

Currently, the immunization program has entered a new era of high-quality development. Implementing the standardized management of vaccination units is a necessary means to achieve the high-quality development of immunization programs. Although significant achievements have been made in vaccination work in China, there are still many urgent problems to be solved in vaccination work under the new situation, which poses new challenges to standardized management of vaccination units. This paper analyzes the problems faced by the standardized management of vaccination units based on a review of the work content at various stages of management, and discusses strategies and suggestions for the standardized management of vaccination units.

当前,免疫规划进入了高质量发展的新时代。实施预防接种单位规范化管理,是实现免疫规划高质量发展的必要手段。尽管中国预防接种工作取得了显著成就,但新形势下预防接种工作仍存在许多亟待解决的问题,这对预防接种单位的规范化管理提出了新的挑战。本文在回顾预防接种单位规范化管理各阶段工作内容的基础上,分析了预防接种单位规范化管理面临的问题,探讨了预防接种单位规范化管理的策略和建议。
{"title":"[Reflections on the standardized management of vaccination units in the new era of high-quality development of China's immunization program].","authors":"B B Wang, J H Tang","doi":"10.3760/cma.j.cn112150-20250115-00040","DOIUrl":"10.3760/cma.j.cn112150-20250115-00040","url":null,"abstract":"<p><p>Currently, the immunization program has entered a new era of high-quality development. Implementing the standardized management of vaccination units is a necessary means to achieve the high-quality development of immunization programs. Although significant achievements have been made in vaccination work in China, there are still many urgent problems to be solved in vaccination work under the new situation, which poses new challenges to standardized management of vaccination units. This paper analyzes the problems faced by the standardized management of vaccination units based on a review of the work content at various stages of management, and discusses strategies and suggestions for the standardized management of vaccination units.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1439-1442"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role and research progress of vitamin D in skin aging]. [维生素D在皮肤衰老中的作用及研究进展]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250215-00110
H Bai, M Wang, S S Zhao, Y Yan

Skin aging is a complex physiological process that is associated with various skin diseases and affects appearance.Vitamin D, a fat-soluble vitamin synthesized after exposure of the skin to ultraviolet B radiation, has been found to regulate skin aging by modulating the physiological functions of skin cells, regulating the immune system, inducing antioxidative responses, inhibiting DNA damage, and promoting its repair. This article elucidates the multi-target mechanism of vitamin D in delaying skin aging, providing a new theoretical foundation for preventive medicine to retard aging and related diseases through nutritional intervention.

皮肤老化是一个复杂的生理过程,与各种皮肤疾病有关,并影响外观。维生素D是一种脂溶性维生素,在皮肤暴露于紫外线B辐射后合成,已被发现通过调节皮肤细胞的生理功能、调节免疫系统、诱导抗氧化反应、抑制DNA损伤和促进其修复来调节皮肤老化。本文阐明了维生素D延缓皮肤衰老的多靶点机制,为预防医学通过营养干预延缓衰老及相关疾病提供新的理论基础。
{"title":"[The role and research progress of vitamin D in skin aging].","authors":"H Bai, M Wang, S S Zhao, Y Yan","doi":"10.3760/cma.j.cn112150-20250215-00110","DOIUrl":"10.3760/cma.j.cn112150-20250215-00110","url":null,"abstract":"<p><p>Skin aging is a complex physiological process that is associated with various skin diseases and affects appearance.Vitamin D, a fat-soluble vitamin synthesized after exposure of the skin to ultraviolet B radiation, has been found to regulate skin aging by modulating the physiological functions of skin cells, regulating the immune system, inducing antioxidative responses, inhibiting DNA damage, and promoting its repair. This article elucidates the multi-target mechanism of vitamin D in delaying skin aging, providing a new theoretical foundation for preventive medicine to retard aging and related diseases through nutritional intervention.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1584-1589"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Improving the coverage rate of human papillomavirus vaccine among adolescent females to contribute to the goal of eliminating cervical cancer in China]. [提高青少年女性人乳头瘤病毒疫苗的覆盖率,为中国消除宫颈癌的目标做出贡献]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250630-00610
A Q Xu, W Z Yang, F H Zhao, X H Pang

China has long prioritized the prevention and control of cervical cancer. In 2023, the National Health Commission and nine other departments jointly formulated the "Action Plan for Accelerating the Elimination of Cervical Cancer (2023-2030)". This article reviews the current global and Chinese progress in eliminating cervical cancer and HPV vaccination efforts. It specifically analyzes the problems and challenges faced in improving the HPV vaccination coverage rate among adolescent females in China. The article articulates the public health value of this improvement in achieving the ultimate goal of eliminating cervical cancer. Furthermore, it proposes targeted technical recommendations, including promptly incorporating HPV vaccination among adolescent females into the National Immunization Plan, formulating and continuously improving vaccination strategies and implementation plans, strengthening science popularization and publicity, and enhancing public opinion monitoring and risk management. These recommendations aim to promote health equity and contribute to the goal of eliminating cervical cancer as soon as possible.

长期以来,中国一直把预防和控制宫颈癌放在优先位置。2023年,国家卫健委等九部门联合制定了《加快消除宫颈癌行动计划(2023-2030年)》。本文综述了目前全球和中国在消除宫颈癌和HPV疫苗接种方面的进展。具体分析了提高中国青春期女性HPV疫苗接种率所面临的问题和挑战。这篇文章阐明了这一改进对实现消除子宫颈癌的最终目标的公共卫生价值。提出有针对性的技术建议,包括及时将女性青少年HPV疫苗接种纳入国家免疫规划,制定并不断完善疫苗接种战略和实施方案,加强科普宣传,加强舆论监测和风险管理。这些建议旨在促进健康公平,并有助于尽快消除子宫颈癌的目标。
{"title":"[Improving the coverage rate of human papillomavirus vaccine among adolescent females to contribute to the goal of eliminating cervical cancer in China].","authors":"A Q Xu, W Z Yang, F H Zhao, X H Pang","doi":"10.3760/cma.j.cn112150-20250630-00610","DOIUrl":"10.3760/cma.j.cn112150-20250630-00610","url":null,"abstract":"<p><p>China has long prioritized the prevention and control of cervical cancer. In 2023, the National Health Commission and nine other departments jointly formulated the \"Action Plan for Accelerating the Elimination of Cervical Cancer (2023-2030)\". This article reviews the current global and Chinese progress in eliminating cervical cancer and HPV vaccination efforts. It specifically analyzes the problems and challenges faced in improving the HPV vaccination coverage rate among adolescent females in China. The article articulates the public health value of this improvement in achieving the ultimate goal of eliminating cervical cancer. Furthermore, it proposes targeted technical recommendations, including promptly incorporating HPV vaccination among adolescent females into the National Immunization Plan, formulating and continuously improving vaccination strategies and implementation plans, strengthening science popularization and publicity, and enhancing public opinion monitoring and risk management. These recommendations aim to promote health equity and contribute to the goal of eliminating cervical cancer as soon as possible.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 ","pages":"1489-1494"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144643689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Distribution characteristics and clinical significance of exposed allergens in different age groups]. 【不同年龄组暴露过敏原分布特点及临床意义】。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250520-00453
R Kong, L M Wang, Y Zhao

Objective: This study aimed to assess the patch test positivity rate, allergen distribution, and their associations with demographic characteristics and immune indicators in patients with allergic contact dermatitis (ACD). Methods: A retrospective medical record analysis was conducted on 402 patients suspected of ACD (338 females, median age 38 years; 64 males, median age 43 years) seen at Xuanwu Hospital, Capital Medical University between June 2023 and June 2024. Standard patch tests (using 100 haptens from the Chinese baseline series) were administered, and serum total IgE and eosinophil levels were measured. Statistical analyses included chi-square tests, t-tests/Mann-Whitney U tests for group comparisons, and Spearman correlation for associations. Results: The overall patch test positivity rate among the 402 patients was 62.69% (252/402), with 85.71% (216/252) showing sensitivity to the top 21 allergens. Predominantly, the affected individuals were females (84.26%, 182/216) aged 19-35 years (36.57%, 79/216). The primary sensitizers were cobalt chloride (22.89%, 92/402) and nickel sulfate (19.90%, 80/402). The highest proportion of severe reactions (+++) was observed with thimerosal (10/16). Males exhibited significantly higher positive risks for carba mix (OR=5.10, P=0.002) and octyl gallate (OR=2.64, P=0.047) compared to females. The age-stratified results revealed that the cobalt chloride positive rate was abnormally increased to 76.72% (50/65) in the 36-50 years age group, a rate significantly higher than those observed in the ≤18 years group (20.00%), the 19-35 years group (21.51%), and the >50 years group (16.13%; all P<0.05). In contrast, the >50 years age group exhibited the highest positive rate for nickel sulfate among all age groups at 20.96% (13/62). No significant correlations were found between the number of positive patch tests, reaction intensity (average/maximum), and total IgE (r=-0.075-0.063), absolute and percentage of eosinophils (P>0.05). Clinically, eczema prevalence in the>50 age group was 22.58% (14/62), with ACD complicated by allergic dermatitis being the most common (16.67%, 36/216). Conclusion: Nickel sulfate and cobalt chloride are primary sensitizers for ACD. Sensitization patterns across age groups are similar and unrelated to IgE/EOS levels. The higher incidence of severe reactions to thimerosal may be linked to heightened sensitization to mercury-containing products like vaccine preservatives. The notably increased cobalt chloride positivity in the 36-50 age group suggests a unique exposure risk, while the higher prevalence in females may be associated with contact with nickel/cobalt-containing items such as jewelry and cosmetics.

目的:探讨过敏性接触性皮炎(ACD)患者的斑贴试验阳性率、过敏原分布及其与人口统计学特征和免疫指标的关系。方法:回顾性分析首都医科大学宣武医院2023年6月至2024年6月收治的疑似ACD患者402例,其中女性338例,中位年龄38岁;男性64例,中位年龄43岁。给予标准斑贴试验(使用来自中国基线系列的100种半抗原),并测量血清总IgE和嗜酸性粒细胞水平。统计分析包括卡方检验、组间比较的t检验/Mann-Whitney U检验和相关性的Spearman相关。结果:402例患者的整体斑贴试验阳性率为62.69%(252/402),其中对前21种过敏原敏感的占85.71%(216/252)。发病个体以19 ~ 35岁女性为主,占84.26%(182/216),占36.57%(79/216)。主要敏化剂为氯化钴(22.89%,92/402)和硫酸镍(19.90%,80/402)。硫柳汞组出现严重反应的比例最高(10/16)。男性对碳水化合物(OR=5.10, P=0.002)和没食子酸辛酯(OR=2.64, P=0.047)的阳性风险显著高于女性。年龄分层结果显示,36-50岁年龄组氯化钴阳性率异常升高,为76.72%(50/65),显著高于≤18岁组(20.00%)、19-35岁组(21.51%)和bbb50岁组(16.13%);P50岁年龄组硫酸镍阳性率最高,为20.96%(13/62)。阳性斑贴试验次数、反应强度(平均/最大)、总IgE (r=-0.075 ~ 0.063)、嗜酸性粒细胞绝对值和百分比之间无显著相关性(P < 0.05)。临床中,50岁以下人群湿疹患病率为22.58%(14/62),其中ACD合并变应性皮炎最为常见(16.67%,36/216)。结论:硫酸镍和氯化钴是ACD的主要致敏剂。不同年龄组的致敏模式相似,且与IgE/EOS水平无关。硫柳汞严重反应的较高发生率可能与对疫苗防腐剂等含汞产品的高度敏化有关。36-50岁年龄组氯化钴阳性显著增加表明存在独特的暴露风险,而女性较高的流行率可能与接触含镍/钴的物品(如珠宝和化妆品)有关。
{"title":"[Distribution characteristics and clinical significance of exposed allergens in different age groups].","authors":"R Kong, L M Wang, Y Zhao","doi":"10.3760/cma.j.cn112150-20250520-00453","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250520-00453","url":null,"abstract":"<p><p><b>Objective:</b> This study aimed to assess the patch test positivity rate, allergen distribution, and their associations with demographic characteristics and immune indicators in patients with allergic contact dermatitis (ACD). <b>Methods:</b> A retrospective medical record analysis was conducted on 402 patients suspected of ACD (338 females, median age 38 years; 64 males, median age 43 years) seen at Xuanwu Hospital, Capital Medical University between June 2023 and June 2024. Standard patch tests (using 100 haptens from the Chinese baseline series) were administered, and serum total IgE and eosinophil levels were measured. Statistical analyses included chi-square tests, <i>t</i>-tests/Mann-Whitney <i>U</i> tests for group comparisons, and Spearman correlation for associations. <b>Results:</b> The overall patch test positivity rate among the 402 patients was 62.69% (252/402), with 85.71% (216/252) showing sensitivity to the top 21 allergens. Predominantly, the affected individuals were females (84.26%, 182/216) aged 19-35 years (36.57%, 79/216). The primary sensitizers were cobalt chloride (22.89%, 92/402) and nickel sulfate (19.90%, 80/402). The highest proportion of severe reactions (+++) was observed with thimerosal (10/16). Males exhibited significantly higher positive risks for carba mix (<i>OR</i>=5.10, <i>P</i>=0.002) and octyl gallate (<i>OR</i>=2.64, <i>P</i>=0.047) compared to females. The age-stratified results revealed that the cobalt chloride positive rate was abnormally increased to 76.72% (50/65) in the 36-50 years age group, a rate significantly higher than those observed in the ≤18 years group (20.00%), the 19-35 years group (21.51%), and the >50 years group (16.13%; all <i>P</i><0.05). In contrast, the >50 years age group exhibited the highest positive rate for nickel sulfate among all age groups at 20.96% (13/62). No significant correlations were found between the number of positive patch tests, reaction intensity (average/maximum), and total IgE (<i>r</i>=-0.075-0.063), absolute and percentage of eosinophils (<i>P</i>>0.05). Clinically, eczema prevalence in the>50 age group was 22.58% (14/62), with ACD complicated by allergic dermatitis being the most common (16.67%, 36/216). <b>Conclusion:</b> Nickel sulfate and cobalt chloride are primary sensitizers for ACD. Sensitization patterns across age groups are similar and unrelated to IgE/EOS levels. The higher incidence of severe reactions to thimerosal may be linked to heightened sensitization to mercury-containing products like vaccine preservatives. The notably increased cobalt chloride positivity in the 36-50 age group suggests a unique exposure risk, while the higher prevalence in females may be associated with contact with nickel/cobalt-containing items such as jewelry and cosmetics.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1414-1421"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current status, challenges and prospects of hierarchical management of vaccination units]. 【预防接种单位分级管理的现状、挑战与展望】。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250304-00166
X Y Wang, Y H Jin, D Hu, X C Wu, Q Li, S S Deng, W Z Yu

To further standardize the management of vaccination units, the Specifications for Vaccination (2023 version) proposes hierarchical management. However, guidelines for establishing, implementing, and evaluating such a framework remain underdeveloped. This paper systematically reviews the current status of hierarchical management in vaccination units, clarifies its feasibility and necessity, and proposes an implementation scheme.

为进一步规范预防接种单位管理,《预防接种规范(2023年版)》提出分级管理。然而,建立、实施和评估这样一个框架的指导方针仍然不发达。本文系统回顾了预防接种单位分级管理的现状,阐明了分级管理的可行性和必要性,并提出了实施方案。
{"title":"[Current status, challenges and prospects of hierarchical management of vaccination units].","authors":"X Y Wang, Y H Jin, D Hu, X C Wu, Q Li, S S Deng, W Z Yu","doi":"10.3760/cma.j.cn112150-20250304-00166","DOIUrl":"10.3760/cma.j.cn112150-20250304-00166","url":null,"abstract":"<p><p>To further standardize the management of vaccination units, the Specifications for Vaccination (2023 version) proposes hierarchical management. However, guidelines for establishing, implementing, and evaluating such a framework remain underdeveloped. This paper systematically reviews the current status of hierarchical management in vaccination units, clarifies its feasibility and necessity, and proposes an implementation scheme.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1443-1447"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expert recommendations for tiered education strategies for allergic rhinitis targeting the public]. [针对公众的过敏性鼻炎分层教育策略的专家建议]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250108-00023

The prevalence of allergic diseases has been steadily increasing worldwide, emerging as a significant global public health concern. Allergic rhinitis, as one of the most common allergic disorders, affects approximately 10% to 40% of the global population. Moreover, allergic rhinitis frequently coexists with other allergic conditions, such as allergic conjunctivitis, allergic asthma, and atopic dermatitis. Its recurrent nature and tendency to manifest as multiple comorbid allergic diseases severely impair patients' quality of life and work productivity, imposing a substantial economic and societal burden on healthcare systems worldwide. Consequently, improving the prevention, control, and management of allergic rhinitis has become an urgent priority for both the general public and the healthcare sector. Effective prevention and comprehensive management of allergic rhinitis require collaborative efforts from patients and various healthcare professionals, including targeted education for different tiers of stakeholders-patients, pharmacists, primary care physicians, and specialists (e.g., allergists, otolaryngologists, and pediatricians). This article propose specific strategies for tiered public education on allergic rhinitis from the perspectives of these four key groups. This approach aims to facilitate tailored, population-wide prevention and control, alleviate the disease burden on individuals and healthcare systems, and establish a foundation for advancing the integrated management of other allergic diseases in the future.

过敏性疾病的患病率在世界范围内稳步上升,成为一个重要的全球公共卫生问题。过敏性鼻炎是最常见的过敏性疾病之一,影响全球约10%至40%的人口。此外,变应性鼻炎经常与其他过敏性疾病共存,如过敏性结膜炎、过敏性哮喘和特应性皮炎。它的复发性和表现为多重共病过敏性疾病的倾向严重损害了患者的生活质量和工作效率,给世界各地的卫生保健系统带来了巨大的经济和社会负担。因此,改善变应性鼻炎的预防、控制和管理已成为公众和医疗保健部门的当务之急。变应性鼻炎的有效预防和综合管理需要患者和各种医疗保健专业人员的共同努力,包括对不同层次的利益相关者(患者、药剂师、初级保健医生和专家(如过敏症专家、耳鼻喉科医生和儿科医生)进行有针对性的教育。本文从这四个重点人群的角度提出了变应性鼻炎分层公众教育的具体策略。该方法旨在促进个性化、全民预防和控制,减轻个人和医疗保健系统的疾病负担,并为未来推进其他变态反应性疾病的综合管理奠定基础。
{"title":"[Expert recommendations for tiered education strategies for allergic rhinitis targeting the public].","authors":"","doi":"10.3760/cma.j.cn112150-20250108-00023","DOIUrl":"10.3760/cma.j.cn112150-20250108-00023","url":null,"abstract":"<p><p>The prevalence of allergic diseases has been steadily increasing worldwide, emerging as a significant global public health concern. Allergic rhinitis, as one of the most common allergic disorders, affects approximately 10% to 40% of the global population. Moreover, allergic rhinitis frequently coexists with other allergic conditions, such as allergic conjunctivitis, allergic asthma, and atopic dermatitis. Its recurrent nature and tendency to manifest as multiple comorbid allergic diseases severely impair patients' quality of life and work productivity, imposing a substantial economic and societal burden on healthcare systems worldwide. Consequently, improving the prevention, control, and management of allergic rhinitis has become an urgent priority for both the general public and the healthcare sector. Effective prevention and comprehensive management of allergic rhinitis require collaborative efforts from patients and various healthcare professionals, including targeted education for different tiers of stakeholders-patients, pharmacists, primary care physicians, and specialists (e.g., allergists, otolaryngologists, and pediatricians). This article propose specific strategies for tiered public education on allergic rhinitis from the perspectives of these four key groups. This approach aims to facilitate tailored, population-wide prevention and control, alleviate the disease burden on individuals and healthcare systems, and establish a foundation for advancing the integrated management of other allergic diseases in the future.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1349-1361"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Proficiency testing for 11 clinical biobanks in Beijing City: simulation study and result analysis]. [北京市11家临床生物库能力测试:模拟研究及结果分析]。
Q3 Medicine Pub Date : 2025-09-06 DOI: 10.3760/cma.j.cn112150-20250522-00465
Q Zhang, Y Zhang, L Han, M Liu, Y B Yu, Y Wang, Y Hu, H Zhong, D Guo, S P Sun, J X Lin, S Y Xu, X K Tang, G Y Sun, C B Zhang, H X Li

Objective: To evaluate the sample preparation proficiency and storage proficiency of 11 clinical biobanks in Beijing through simulated experiments, and to establish an assessment method for the quality comparability of biological samples. Methods: An exploratory research design was adopted. In November 2023, artificial composite serum quality control materials containing six recombinant human protein markers-recombinant human alanine aminotransferase (rhALT), recombinant human aspartate aminotransferase (rhAST), recombinant human creatine kinase (rhCK), recombinant human creatine kinase-MB (rhCK-MB), recombinant human B-type natriuretic peptide (rhBNP), and recombinant human troponin I (rhTNI)-were distributed to 11 clinical biobanks in Beijing City. Sample preparation and storage followed the standardized operating procedures. Proficiency differences were assessed through statistical analysis. Results: Three-way repeated measures ANOVA revealed all six protein markers showed a declining trend over storage time in ultra-low-temperature environments (F values 11.68-4 179.66, all P<0.01). However, neither long-term/temporary refrigerator types (F values 0.01-1.23, all P>0.05)nor placement locations within refrigerators significantly affected the stability of these six proteins (F valus 0.03-1.47, all P>0.05). The biases in detection results for rhALT, rhAST, rhTNI, and rhBNP at different storage time points were within the allowable bias limits for each item, supporting their use as markers for protein stability in biobank samples. All 11 institutions passed the storage proficiency assessment. In the preparation proficiency assessment, deviations were observed in post-preparation sample results, with a notably high out-of-control rate for rhCK (36.36%). Conclusion: Sample preparation proficiency can serve as a quality control metric for clinical biobanks. Future external quality assessment systems for biobanks should focus on sample preparation rather than storage processes.

目的:通过模拟实验对北京市11家临床生物库的样品制备熟练度和储存熟练度进行评价,建立生物样品质量可比性评价方法。方法:采用探索性研究设计。2023年11月,将含有重组人丙氨酸转氨酶(rhALT)、重组人天冬氨酸转氨酶(rast)、重组人肌酸激酶(rhCK)、重组人肌酸激酶- mb (rhCK- mb)、重组人b型利钠肽(rhBNP)、重组人肌钙蛋白I (rhTNI) 6种重组蛋白标记物的人工合成血清质控材料分发至北京市11家临床生物库。样品制备和储存遵循标准化操作程序。通过统计分析评估熟练程度差异。结果:三向重复测量方差分析显示,6种蛋白标记物在超低温环境下贮存时间均呈下降趋势(F值为11.68 ~ 4 179.66,所有PF值为0.01 ~ 1.23,所有P>0.05),而冰箱内放置位置对6种蛋白的稳定性影响不显著(F值为0.03 ~ 1.47,所有P>0.05)。rhALT、rast、rhTNI和rhBNP在不同储存时间点的检测结果偏差均在允许的偏差范围内,支持它们作为生物库样品中蛋白质稳定性的标记物。11家机构全部通过仓储能力考核。在制备熟练度评价中,制备后样品结果存在偏差,其中rhCK的失控率较高(36.36%)。结论:样品制备熟练度可作为临床生物库的质量控制指标。未来生物库的外部质量评估系统应侧重于样品制备而不是储存过程。
{"title":"[Proficiency testing for 11 clinical biobanks in Beijing City: simulation study and result analysis].","authors":"Q Zhang, Y Zhang, L Han, M Liu, Y B Yu, Y Wang, Y Hu, H Zhong, D Guo, S P Sun, J X Lin, S Y Xu, X K Tang, G Y Sun, C B Zhang, H X Li","doi":"10.3760/cma.j.cn112150-20250522-00465","DOIUrl":"10.3760/cma.j.cn112150-20250522-00465","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the sample preparation proficiency and storage proficiency of 11 clinical biobanks in Beijing through simulated experiments, and to establish an assessment method for the quality comparability of biological samples. <b>Methods:</b> An exploratory research design was adopted. In November 2023, artificial composite serum quality control materials containing six recombinant human protein markers-recombinant human alanine aminotransferase (rhALT), recombinant human aspartate aminotransferase (rhAST), recombinant human creatine kinase (rhCK), recombinant human creatine kinase-MB (rhCK-MB), recombinant human B-type natriuretic peptide (rhBNP), and recombinant human troponin I (rhTNI)-were distributed to 11 clinical biobanks in Beijing City. Sample preparation and storage followed the standardized operating procedures. Proficiency differences were assessed through statistical analysis. <b>Results:</b> Three-way repeated measures ANOVA revealed all six protein markers showed a declining trend over storage time in ultra-low-temperature environments (<i>F</i> values 11.68-4 179.66, all <i>P</i><0.01). However, neither long-term/temporary refrigerator types (<i>F</i> values 0.01-1.23, all <i>P</i>>0.05)nor placement locations within refrigerators significantly affected the stability of these six proteins (<i>F</i> valus 0.03-1.47, all <i>P</i>>0.05). The biases in detection results for rhALT, rhAST, rhTNI, and rhBNP at different storage time points were within the allowable bias limits for each item, supporting their use as markers for protein stability in biobank samples. All 11 institutions passed the storage proficiency assessment. In the preparation proficiency assessment, deviations were observed in post-preparation sample results, with a notably high out-of-control rate for rhCK (36.36%). <b>Conclusion:</b> Sample preparation proficiency can serve as a quality control metric for clinical biobanks. Future external quality assessment systems for biobanks should focus on sample preparation rather than storage processes.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 9","pages":"1590-1596"},"PeriodicalIF":0.0,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145070711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华预防医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1